Alternatives to CureVac

Moderna is a biotechnology company pioneering mRNA medicine, best known for its COVID-19 vaccine and a broad pipeline of mRNA-based therapeutics.

Develops bacteria-based immunotherapy to enhance anti-tumor immunity for cancer treatment.

Pioneering vision restoration therapies for severe retinal degenerations.

Biopharmaceutical company developing innovative therapies for sepsis and intensive care.

A global oncology company developing and commercializing innovative cancer treatments.

Developing engineered biologics to harness the immune system for disease treatment.

Caris Life Sciences is a leading innovator in molecular science, offering precision medicine solutions for cancer patients through advanced molecular profiling.

Guardant Health is a precision oncology company that develops and commercializes liquid biopsy tests for cancer detection, recurrence monitoring, and treatment selection.

A clinical-stage oncology company developing DNA interference (DNAi) based cancer therapies.

Biotech company using AI and computational platforms to design novel peptide therapeutics.

Biotechnology company developing novel immunotherapies for cancer.

Clinical-stage biotechnology company developing Antibody Oligonucleotide Conjugates (AOCs) for serious diseases.

Leap Therapeutics is a clinical-stage biopharmaceutical company focused on developing novel targeted and immuno-oncology therapies.

Biopharmaceutical company developing antibody-based therapeutics for cancer and autoimmune diseases.

Biopharmaceutical company developing novel cancer therapies using targeted protein degradation.

Clinical-stage biotechnology company developing allogeneic gamma delta T cell therapies for cancer and autoimmune diseases.

Develops novel protein engineering and directed evolution technologies for therapeutic discovery.

Developing novel therapeutics for challenging diseases using advanced biological insights.

Develops and manufactures biologics for therapeutic applications.

AI platform for drug discovery and development, optimizing targets, compounds, and combination therapies.